Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lactobacillus species have been investigated for their potential role in supporting oral health, including the management of gingivitis. Several clinical trials and systematic reviews have explored the effects of specific Lactobacillus strains (such as L. reuteri, L. salivarius, and L. rhamnosus) on gingival inflammation and plaque accumulation. These studies suggest that certain strains, when administered as probiotics in lozenges, tablets, or dairy products, may modestly reduce gingival bleeding and inflammation compared to placebo. The proposed mechanisms include modulation of the oral microbiota, competitive inhibition of pathogenic bacteria, and anti-inflammatory effects. However, the term "Lactobacillus (unspecified)" is broad, and not all Lactobacillus strains have been shown to be effective or even studied for this specific indication.

The quality of evidence is variable, with some studies having small sample sizes, short durations, or methodological limitations. Meta-analyses (e.g., by Gruner et al., 2016, and other reviews up to 2023) conclude that while there is some support for probiotic Lactobacillus in reducing gingivitis symptoms, the effect size is generally small and clinical relevance remains uncertain. Furthermore, most guidelines do not yet recommend probiotics as a stand-alone or primary therapy for gingivitis.

In summary, the use of certain Lactobacillus strains for gingivitis has some scientific basis, but the evidence is modest and strain-specific. Claims about "Lactobacillus" in general are not fully substantiated, and more rigorous research is needed to determine efficacy and optimal usage.

More about Lactobacillus (unspepcified)
More about Gingivitis

Other ingredients used for Gingivitis

Other health conditions supported by Lactobacillus (unspepcified)

Products containing Lactobacillus (unspepcified)